Diabetes Complications
Lipid lowering agents may reduce the risk for diabetes-related vision loss
Published in Obesity and Diabetes Week, January 24th, 2005
"We evaluated the relationships between serum lipid levels and clinically significant macular edema (CSME), hard exudates, and other diabetic retinopathy (DR) end points in a population with type 1 diabetes. We studied data from serum lipids that were measured annually among the 1441 Diabetes Control and Complications Trial (DCCT) participants," scientists in the United States report.
"We used proportional hazards regression models to examine the relationship of the cumulative average of lipid levels (total, low-density lipoprotein (LDL), and high-density lipoprotein (HDL)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Findings describe new data in diabetes pathogenesis research - Diabetes Pathogenesis
Studies advance knowledge in diabetes pathogenesis research - Diabetes Therapy
Pioglitazone restores impaired glucose-stimulated insulin secretion - Obesity and Diabetes
Age has independent effect on insulin sensitivity and beta-cell function - Obesity and Diabetes
Beta-cell function and insulin sensitivity associated with body fatness - Obesity and Diabetes
Free fatty acid levels modulate microvascular function - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
